These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9215122)

  • 21. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D; Li KZ; Dou KF; Gao ZQ; Song ZS; Zhao QC; Fu YC
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov; 20(6):721-2. PubMed ID: 15555445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma.
    EI-Emshaty HM; Saad EA; Toson EA; Abdel Malak CA; Gadelhak NA
    Hepatogastroenterology; 2014; 61(133):1393-401. PubMed ID: 25436317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia.
    Cohen C; DeRose PB
    Mod Pathol; 1994 Jun; 7(5):536-9. PubMed ID: 7937718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell proliferation index and the expression of p53 and Bcl-2 in tumorous and non-tumorous lesions of hepatocellular carcinoma and metastatic liver cancer.
    Yoon DS; Cheong JH; Park YN; Kwon SW; Chi HS; Kim BR
    Yonsei Med J; 1998 Oct; 39(5):424-9. PubMed ID: 9821791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver cell dysplasia: reactivities for c-met protein, Rb protein, E-cadherin and transforming growth factor-beta 1 in comparison with hepatocellular carcinoma.
    Zhao M; Zimmermann A
    Histol Histopathol; 1998 Jul; 13(3):657-70. PubMed ID: 9690121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
    Kushner J; Bradley G; Jordan RC
    J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma.
    Nakopoulou L; Janinis J; Giannopoulou I; Lazaris AC; Koureas A; Zacharoulis D
    Pathol Res Pract; 1995 Dec; 191(12):1208-13. PubMed ID: 8927568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
    Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
    J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crosstalk between EGFR and p53 in hepatocellular carcinoma.
    Cioca A; Cimpean A; Ceausu R; Fit AM; Zaharie T; Al-Hajjar N; Puia V; Raica M
    Asian Pac J Cancer Prev; 2014; 15(19):8069-73. PubMed ID: 25338986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RBP-J-interacting and tubulin-associated protein induces apoptosis and cell cycle arrest in human hepatocellular carcinoma by activating the p53-Fbxw7 pathway.
    Wang H; Yang Z; Liu C; Huang S; Wang H; Chen Y; Chen G
    Biochem Biophys Res Commun; 2014 Nov; 454(1):71-7. PubMed ID: 25445601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p57(kip2) and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma.
    Nan KJ; Guo H; Ruan ZP; Jing Z; Liu SX
    World J Gastroenterol; 2005 Feb; 11(8):1237-40. PubMed ID: 15754413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-linked inhibitor of apoptosis (XIAP) and XIAP-associated factor-1 expressions and their relationship to apoptosis in human hepatocellular carcinoma and non-cancerous liver tissues.
    Sakemi R; Yano H; Ogasawara S; Akiba J; Nakashima O; Fukahori S; Sata M; Kojiro M
    Oncol Rep; 2007 Jul; 18(1):65-70. PubMed ID: 17549347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S; Saji S; Kuno T
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of WWP1 inhibits growth and induces apoptosis in hepatoma carcinoma cells through the activation of caspase3 and p53.
    Cheng Q; Cao X; Yuan F; Li G; Tong T
    Biochem Biophys Res Commun; 2014 Jun; 448(3):248-54. PubMed ID: 24792179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and p53 protein and their significance in human hepatocellular carcinomas].
    Cheng LM; Wang SY; Lin JS
    Ai Zheng; 2003 Jan; 22(1):42-5. PubMed ID: 12561434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Karyometric analysis of liver cell dysplasia and hepatocellular carcinoma. Evidence against precancerous nature of liver cell dysplasia.
    Henmi A; Uchida T; Shikata T
    Cancer; 1985 Jun; 55(11):2594-9. PubMed ID: 2986818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
    Choi YL; Park SH; Jang JJ; Park CK
    J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma.
    Guo RP; Zhong C; Shi M; Zhang CQ; Wei W; Zhang YQ; Li JQ
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):547-55. PubMed ID: 16763805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
    Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
    Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.